Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Treasury Shares: 2023-2025

Historic Treasury Shares for InMed Pharmaceuticals (INM) over the last 2 years, with Sep 2025 value amounting to $3.9 million.

  • InMed Pharmaceuticals' Treasury Shares rose 673.00% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year increase of 673.00%. This contributed to the annual value of $4.5 million for FY2025, which is 734.35% up from last year.
  • According to the latest figures from Q3 2025, InMed Pharmaceuticals' Treasury Shares is $3.9 million, which was down 13.26% from $4.5 million recorded in Q2 2025.
  • In the past 5 years, InMed Pharmaceuticals' Treasury Shares ranged from a high of $13.2 million in Q1 2024 and a low of $42,096 during Q1 2025.
  • Its 3-year average for Treasury Shares is $2.6 million, with a median of $544,280 in 2024.
  • The largest annual percentage gain for InMed Pharmaceuticals' Treasury Shares in the last 5 years was 734.35% (2025), contrasted with its biggest fall of 99.68% (2025).
  • Quarterly analysis of 3 years shows InMed Pharmaceuticals' Treasury Shares stood at $559,267 in 2023, then slumped by 91.56% to $47,176 in 2024, then spiked by 673.00% to $3.9 million in 2025.
  • Its Treasury Shares stands at $3.9 million for Q3 2025, versus $4.5 million for Q2 2025 and $42,096 for Q1 2025.